Identification of cytokine release syndrome and indicators of severity in retrospective databases among patients receiving immunotherapy

Identification of cytokine release syndrome and indicators of severity in retrospective databases among patients receiving immunotherapy

Abstract Cytokine release syndrome (CRS) can occur following cancer immunotherapies, but is most often mild and of limited duration. International Classification of Diseases (ICD)‐10 codes allowing identification of CRS were introduced in 2020 but may be underutilized. We evaluated the performance o...

Full description

Saved in:
Bibliographic Details
Main Authors: Scott F. Huntington, Dee Lin, Marie‐Hélène Lafeuille, Philippe Thompson‐Leduc, Aditi Shah, Nina Kim, Laura Hester, Anabelle Tardif‐Samson, Bronwyn Moore, Jessica Fowler, Alexander Marshall, Xinke Zhang, Dina Gifkins, Bingcao Wu
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Pharmacology Research & Perspectives
Subjects:
administrative claims
bispecific antibodies
chimeric antigen receptors
cytokine release syndrome
drug‐related side effects and adverse reactions
electronic health records
Online Access:https://doi.org/10.1002/prp2.70024
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/prp2.70024

Similar Items